In a single-center, double-blind, noninferiority trial involving adults with unipolar depression, we randomly assigned patients to receive tDCS plus oral placebo, sham tDCS plus escitalopram, or sham ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results